As of September 30, 2024, Fortress' consolidated cash and cash equivalents totaled $58.9 million, compared to $76.2 million ...

Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the "Company", "Kane Biotech") announces today that it has entered into a binding term sheet (the "Term ...

Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the "Company", "Kane Biotech") announces today that President & CEO, Marc Edwards and Dr. Robert Huizinga ...

The Biotechnology Innovation Organization (BIO) has commended a recent update from the USDA's Animal and Plant Health Inspection Service (APHIS), which has expanded exemptions for genetically modified ...

About Chemomab Therapeutics Ltd. Chemomab is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need. Based on the unique role of ...

The potential anchor tenant, a biotech firm based in the innovation district, is being recruited by other cities.

Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...

The concept of the blue economy represents a crucial framework for sustainable development, highlighting the economic potential of ocean resources while promoting environmental management. This specia ...

Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...

Thermo Fisher Scientific has signed an agreement with German molecular genetics company Mainz Biomed, the developer of ...

A commercial real estate and life sciences networking and disucssion event exploring the key people, projects, and potential ...

Fannin Innovation’s Managing Partner discusses strategies, challenges in biotech investment, and what sets Fannin’s model ...